Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Synergism between Prior Anisakis simplex Infections and Intake of NSAIDs, on the Risk of Upper Digestive Bleeding: A Case-Control Study.

PMID: 21738810
Journal: PLoS Neglected Tropical Diseases
Year: 2011
Reference: PLoS Negl Trop Dis. 2011 Jun;5(6):e1214. Epub 2011 Jun 28.
Impact factor: 4.752
Publication type: Paper in international publication
Authors: Lopez-Goikoetxea, Maria Jose, Ibanez, Luisa, Figueiras, Adolfo, Aguirre, Carmelo, Ortega, Sara, Salgado, Angel, Ubeira, Florencio M, Anadon, Ana M, Carvajal, Alfonso et al.
DOI: 10.1371/journal.pntd.0001214

Synergism between Prior Anisakis simplex Infections and Intake of NSAIDs, on the Risk of Upper Digestive Bleeding: A Case-Control Study.

PMID: 21738810
Journal: PLoS Neglected Tropical Diseases
Year: 2011
Reference: PLoS Negl Trop Dis. 2011 Jun;5(6):e1214. Epub 2011 Jun 28.
Impact factor:
Publication type: Paper in international publication
Authors: Aguirre, Carmelo; Anadon, Ana M; Carvajal, Alfonso; Figueiras, Adolfo; Ibanez, Luisa; Lopez-Goikoetxea, Maria Jose; Ortega, Sara; Salgado, Angel; Ubeira, Florencio M et al.
DOI: 10.1371/journal.pntd.0001214

Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism.

PMID: 21600050
Journal: BREAST CANCER RESEARCH
Year: 2011
Reference: Breast Cancer Res. 2011 May 22;13(3):R54.
Impact factor: 5.785
Publication type: Paper in international publication
Authors: , , , et al.
DOI: 10.1186/bcr2888

Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism.

PMID: 21600050
Journal: BREAST CANCER RESEARCH
Year: 2011
Reference: Breast Cancer Res. 2011 May 22;13(3):R54.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; et al.
DOI: 10.1186/bcr2888

Synovial fibroblast hyperplasia in rheumatoid arthritis: Clinicopathological correlations and partial reversal by anti-tumor necrosis factor therapy.

PMID: 21547893
Journal: ARTHRITIS AND RHEUMATISM
Year: 2011
Reference: Arthritis Rheum. 2011 Sep;63(9):2575-83. doi: 10.1002/art.30433.
Impact factor: 8.435
Publication type: Paper in international publication
Authors: , , , , , , , , et al.
DOI: 10.1002/art.30433

Synovial fibroblast hyperplasia in rheumatoid arthritis: Clinicopathological correlations and partial reversal by anti-tumor necrosis factor therapy.

PMID: 21547893
Journal: ARTHRITIS AND RHEUMATISM
Year: 2011
Reference: Arthritis Rheum. 2011 Sep;63(9):2575-83. doi: 10.1002/art.30433.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; et al.
DOI: 10.1002/art.30433

Systematic reviews and meta-analysis: scientific rationale and interpretation.

PMID: 21719182
Journal: REVISTA ESPANOLA DE CARDIOLOGIA
Year: 2011
Reference: Rev Esp Cardiol. 2011 Aug;64(8):688-96. Epub 2011 Jun 30.
Impact factor: 2.157
Publication type: Review in national publication
Authors: Ferreira Gonzalez, Ignacio, Urrutia, Gerard, Alonso-Coello, Pablo et al.
DOI: 10.1016/j.recesp.2011.03.029

Systematic reviews and meta-analysis: scientific rationale and interpretation.

PMID: 21719182
Journal: REVISTA ESPANOLA DE CARDIOLOGIA
Year: 2011
Reference: Rev Esp Cardiol. 2011 Aug;64(8):688-96. Epub 2011 Jun 30.
Impact factor:
Publication type: Review in national publication
Authors: Alonso-Coello, Pablo; Ferreira Gonzalez, Ignacio; Urrutia, Gerard et al.
DOI: 10.1016/j.recesp.2011.03.029

Systemic lupus erythematosus as a first presentation of common variable immunodeficiency associated with infrequent mannose-binding lectin gene polymorphisms.

PMID: 19851769
Journal: RHEUMATOLOGY INTERNATIONAL
Year: 2011
Reference: Rheumatol Int. 2011 Apr;31(4):537-41. Epub 2009 Oct 23.
Impact factor: 1.431
Publication type: Paper in international publication
Authors: , , , , et al.
DOI: 10.1007/s00296-009-1209-8

Systemic lupus erythematosus as a first presentation of common variable immunodeficiency associated with infrequent mannose-binding lectin gene polymorphisms.

PMID: 19851769
Journal: RHEUMATOLOGY INTERNATIONAL
Year: 2011
Reference: Rheumatol Int. 2011 Apr;31(4):537-41. Epub 2009 Oct 23.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; et al.
DOI: 10.1007/s00296-009-1209-8

T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.

PMID: 20627965
Journal: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Year: 2011
Reference: J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):72-7. Epub 2010 Jul 13.
Impact factor: 4.791
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1136/jnnp.2009.201574

T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.

PMID: 20627965
Journal: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Year: 2011
Reference: J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):72-7. Epub 2010 Jul 13.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1136/jnnp.2009.201574

Targeted impairment of thymidine kinase 2 expression in cells induces mitochondrial DNA depletion and reveals molecular mechanisms of compensation of mitochondrial respiratory activity.

PMID: 21382338
Journal: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Year: 2011
Reference: Biochem Biophys Res Commun. 2011 Apr 8;407(2):333-8. Epub 2011 Mar 5.
Impact factor: 2.595
Publication type: Paper in international publication
Authors: , , , , , , , et al.
DOI: 10.1016/j.bbrc.2011.03.018

Targeted impairment of thymidine kinase 2 expression in cells induces mitochondrial DNA depletion and reveals molecular mechanisms of compensation of mitochondrial respiratory activity.

PMID: 21382338
Journal: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Year: 2011
Reference: Biochem Biophys Res Commun. 2011 Apr 8;407(2):333-8. Epub 2011 Mar 5.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; et al.
DOI: 10.1016/j.bbrc.2011.03.018

Targeted therapies development in the treatment of advanced nonsmall cell lung cancer.

PMID: 22219656
Journal: JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
Year: 2011
Reference: J Biomed Biotechnol. 2011;2011:415641. Epub 2011 Dec 18.
Impact factor: 1.225
Publication type: Editorail in international publication
Authors: Gridelli, Cesare, Felip, Enriqueta et al.
DOI: 10.1155/2011/415641

Targeted therapies development in the treatment of advanced nonsmall cell lung cancer.

PMID: 22219656
Journal: JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
Year: 2011
Reference: J Biomed Biotechnol. 2011;2011:415641. Epub 2011 Dec 18.
Impact factor:
Publication type: Editorail in international publication
Authors: Felip, Enriqueta; Gridelli, Cesare et al.
DOI: 10.1155/2011/415641

Telaprevir for retreatment of HCV infection.

PMID: 21696308
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2011
Reference: N Engl J Med. 2011 Jun 23;364(25):2417-28.
Impact factor: 53.484
Publication type: Paper in international publication
Authors: Picchio, Gaston, Pol, Stanislas, Lawitz, Eric, Diago, Moises, Roberts, Stuart, Focaccia, Roberto, Younossi, Zobair, Foster, Graham R, Horban, Andrzej, Ferenci, Peter et al.
DOI: 10.1056/NEJMoa1013086

Telaprevir for retreatment of HCV infection.

PMID: 21696308
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2011
Reference: N Engl J Med. 2011 Jun 23;364(25):2417-28.
Impact factor:
Publication type: Paper in international publication
Authors: Afdhal, Nezam; Agarwal, Kaushik; Andreone, Pietro; Andreone, Pietro; Arora, Sanjeev; Ascione, Antonio; Baruch, Yaacov; Benari, Ziv; Benhamou, Yves; Berg, Thomas et al.
DOI: 10.1056/NEJMoa1013086

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.

PMID: 21254162
Journal: HEPATOLOGY
Year: 2011
Reference: Hepatology. 2011 Jan;53(1):62-72. doi: 10.1002/hep.23952. Epub 2010 Oct 27.
Impact factor: 10.885
Publication type: Paper in international publication
Authors: Liaw, Yun-Fan, Sheen, I-Shyan, Lee, Chuan-Mo, Akarca, Ulus Salih, Papatheodoridis, George V, Suet-Hing Wong, Florence, Chang, Ting-Tsung, Horban, Andrzej, Wang, Chia, Kwan, Peter et al.
DOI: 10.1002/hep.23952

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.

PMID: 21254162
Journal: HEPATOLOGY
Year: 2011
Reference: Hepatology. 2011 Jan;53(1):62-72. doi: 10.1002/hep.23952. Epub 2010 Oct 27.
Impact factor:
Publication type: Paper in international publication
Authors: Akarca, Ulus Salih; Berg, Thomas; Buti, Maria; Chang, Ting-Tsung; Frederick, David; Horban, Andrzej; Kitrinos, Kathryn; Kwan, Peter; Lee, Chuan-Mo; Liaw, Yun-Fan et al.
DOI: 10.1002/hep.23952

THC and CBD oromucosal spray (Sativex((R))) in the management of spasticity associated with multiple sclerosis.

PMID: 21456949
Journal: Expert review of neurotherapeutics
Year: 2011
Reference: Expert Rev Neurother. 2011 May;11(5):627-37. Epub 2011 Apr 1.
Impact factor:
Publication type: Letter or abstract
Authors: , , , et al.
DOI: 10.1586/ern.11.47

THC and CBD oromucosal spray (Sativex((R))) in the management of spasticity associated with multiple sclerosis.

PMID: 21456949
Journal: Expert review of neurotherapeutics
Year: 2011
Reference: Expert Rev Neurother. 2011 May;11(5):627-37. Epub 2011 Apr 1.
Impact factor:
Publication type: Letter or abstract
Authors: ; ; ; et al.
DOI: 10.1586/ern.11.47

The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy.

PMID: 21811581
Journal: PLoS One
Year: 2011
Reference: PLoS One. 2011;6(7):e22284. Epub 2011 Jul 21.
Impact factor: 4.411
Publication type: Paper in international publication
Authors: Annibali, Daniela, Carucci, Nicoletta, Favuzzi, Emilia, Cole, Michael D, Evan, Gerard I, Soucek, Laura, Nasi, Sergio, Savino, Mauro et al.
DOI: 10.1371/journal.pone.0022284

The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy.

PMID: 21811581
Journal: PLoS One
Year: 2011
Reference: PLoS One. 2011;6(7):e22284. Epub 2011 Jul 21.
Impact factor:
Publication type: Paper in international publication
Authors: Annibali, Daniela; Carucci, Nicoletta; Cole, Michael D; Evan, Gerard I; Favuzzi, Emilia; Nasi, Sergio; Savino, Mauro; Soucek, Laura et al.
DOI: 10.1371/journal.pone.0022284